Site icon Occasional Digest

AstraZeneca PLC Non-GAAP EPS of $2.79, revenue of $16.21B beats by $210M; reaffirms FY2026

Finance Desk

  • AstraZeneca PLC press release (AZN): Q3 Non-GAAP EPS of $2.79.
  • Revenue of $16.21B (+6.7% Y/Y) beats by $210M.
  • FY2026 Guidance AstraZeneca reconfirms: Total Revenue is expected to increase by a mid-to-high single-digit percentage.
  • Core EPS is expected to increase

Source link

Exit mobile version